- Home
- CDIO vs MOB Comparison
CDIO vs MOB Comparison
Compare CDIO & MOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- MOB
- Stock Information
- Founded
- CDIO 2017
- MOB 2008
- Country
- CDIO United States
- MOB Israel
- Employees
- CDIO N/A
- MOB N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- MOB Real Estate Investment Trusts
- Sector
- CDIO Health Care
- MOB Real Estate
- Exchange
- CDIO Nasdaq
- MOB Nasdaq
- Market Cap
- CDIO 19.5M
- MOB 15.8M
- IPO Year
- CDIO N/A
- MOB 2022
- Fundamental
- Price
- CDIO $0.48
- MOB $1.79
- Analyst Decision
- CDIO Buy
- MOB
- Analyst Count
- CDIO 1
- MOB 0
- Target Price
- CDIO $2.00
- MOB N/A
- AVG Volume (30 Days)
- CDIO 763.1K
- MOB 91.8K
- Earning Date
- CDIO 05-14-2025
- MOB 05-02-2025
- Dividend Yield
- CDIO N/A
- MOB N/A
- EPS Growth
- CDIO N/A
- MOB N/A
- EPS
- CDIO N/A
- MOB N/A
- Revenue
- CDIO $34,890.00
- MOB $3,180,565.00
- Revenue This Year
- CDIO $1,434.82
- MOB N/A
- Revenue Next Year
- CDIO $4,661.91
- MOB N/A
- P/E Ratio
- CDIO N/A
- MOB N/A
- Revenue Growth
- CDIO 104.45
- MOB 44.98
- 52 Week Low
- CDIO $0.19
- MOB $0.71
- 52 Week High
- CDIO $1.77
- MOB $5.00
- Technical
- Relative Strength Index (RSI)
- CDIO 68.01
- MOB 45.69
- Support Level
- CDIO $0.30
- MOB $1.38
- Resistance Level
- CDIO $0.43
- MOB $1.90
- Average True Range (ATR)
- CDIO 0.06
- MOB 0.20
- MACD
- CDIO 0.02
- MOB 0.04
- Stochastic Oscillator
- CDIO 90.15
- MOB 56.22
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About MOB Mobilicom Limited
Mobilicom Ltd is a provider of cybersecurity and smart solutions for drones, robotics & autonomous platforms. As a high-tech company, it designs, develops, and delivers smart solutions targeting global drone, robotics, and autonomous system manufacturers.